Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating albumin-bound docetaxel in combination with bevacizumab for platinum-resistant recurrent ovarian cancer is in early stages w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platinum-resistant Recurrent Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Docetaxel for Injection (Albumin Bound) (docetaxel (albumin-bound formulation))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Platinum-resistant Recurrent Ovarian Cancer | Phase 2 | Status: UNKNOWN